Image pharmaphorum Editor Views & Analysis How big pharma and startups can learn from each other Francesca Wuttke’s varied career has taken her from research roles to private equity and now to the role of chief digital officer at Almirall. Views & Analysis Could AI create a brave new world of pharma R&D? Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines. Views & Analysis From narrow AI to broad AI As director of global life sciences at IBM Watson Health, Christina Busmalis is well placed to know how AI is set to transform life sciences. Views & Analysis Harnessing the potential of AI in commercial life sciences Artificial intelligence (AI) has gained significant momentum in life sciences over the past few years. Load more results
Views & Analysis How big pharma and startups can learn from each other Francesca Wuttke’s varied career has taken her from research roles to private equity and now to the role of chief digital officer at Almirall.
Views & Analysis Could AI create a brave new world of pharma R&D? Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines.
Views & Analysis From narrow AI to broad AI As director of global life sciences at IBM Watson Health, Christina Busmalis is well placed to know how AI is set to transform life sciences.
Views & Analysis Harnessing the potential of AI in commercial life sciences Artificial intelligence (AI) has gained significant momentum in life sciences over the past few years.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.